#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Retinitis pigmentosa Thymic carcinoma Cytokine release syndrome Brain injury Enteritis Hyperadrenocorticism Prodromal Alzheimer's disease Li-Fraumeni syndrome Hypocalcaemia Haemophagocytic lymphohistiocytosis Stress cardiomyopathy Gaucher's disease type III Congenital ectodermal dysplasia Fungal infection Colon cancer More trials…

    Learn about Rare Diseases

    Carcinoid syndrome – Trials in Disease Aicardi-Goutieres syndrome Stevens-Johnson syndrome – Diagnostics Gastrointestinal stromal tumour – Basic Information Ewing’s sarcoma metastatic – Diagnostics Burkitt’s lymphoma – Trials in Disease Activated PI3 kinase delta syndrome – Basic Information Acquired haemophilia – Basic Information Von Willebrand’s disease – Basic Information VEXAS syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    DISODIUM PHOSPHATE Mps-214 Warfarin Sodium HYDROGEN PEROXIDE BMS-986365 Moxifloxacin Hydrochloride Paraffin White Soft Xevinapant Memantine Hydrochloride Vildagliptin Anakinra Anhydrous Caffeine Mdna11 Technetium (99Mtc) Donanemab Estradiol Hemihydrate Tildrakizumab Chlorphenamine Maleate Nadroparin Calcium HSP-CAR30 More therapies…

    Learn about Your Condition

    Urticaria Epileptic encephalopathy Infective uveitis Chronic myeloid leukaemia Cold type haemolytic anaemia Spinal pain B-cell type acute leukaemia Phenylketonuria Dystonia Angelman's syndrome Mitral valve disease Cerebrovascular accident Peritoneal sarcoma Noninfective chorioretinitis Astrocytoma malignant More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Therapeutics

  • Study on the Effectiveness of Aprepitant and Fosaprepitant in Preventing Nausea and Vomiting in Children Undergoing Chemotherapy

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Prophylaxis of nausea and vomiting
    Investigated Drugs:
    • Fosaprepitant
    • Aprepitant
    The Netherlands

  • Study on the Effects of Hyperbaric Oxygen Therapy for Patients with Moderate-to-Severe Ulcerative Colitis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Oxygen
    The Netherlands

  • Study on Rituximab for Patients with Relapsing Polymyalgia Rheumatica to Reduce Steroid Use

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Polymyalgia rheumatica
    Investigated Drugs:
    • Rituximab
    The Netherlands

  • Study on Induction Chemotherapy with Irinotecan, Folinic Acid, Fluorouracil, and Oxaliplatin for Patients with High-Risk Locally Advanced Rectal Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Rectal cancer
    Investigated Drugs:
    • Irinotecan Hydrochloride Trihydrate
    • Fluorouracil
    • Folinic Acid
    The Netherlands

  • Study on Continuing or Stopping Immunosuppressive Therapy with Rituximab in Patients with ANCA Vasculitis and End-stage Kidney Disease

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • End stage renal disease
    • Anti-neutrophil cytoplasmic antibody positive vasculitis
    Investigated Drugs:
    • Azathioprine
    • Mycophenolate Mofetil
    • Prednisone
    France

  • Study on Cefepime for Patients with Chronic Kidney Disease on Peritoneal Dialysis Without Peritonitis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Peritoneal dialysis
    Investigated Drugs:
    • Cefepime
    Austria
Previous Page
1 … 20 21 22 23 24
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!